Hong Kong Food Stock News

Far East Horizon Limited's ( HKG:3360 ) price-to-earnings (or "P/E") ratio of 8x might make it look like a buy right...

It hasn't been the best quarter for Bank of Qingdao Co., Ltd. ( HKG:3866 ) shareholders, since the share price has...

AInnovation Technology Group Co., Ltd ( HKG:2121 ) shares have had a really impressive month, gaining 25% after a shaky...

Key Insights Significant insider control over NetDragon Websoft Holdings implies vested interests in company growth A...

To the annoyance of some shareholders, IVD Medical Holding Limited ( HKG:1931 ) shares are down a considerable 38% in...

Kuaishou Technology ( HKG:1024 ) shareholders would be excited to see that the share price has had a great month...

Smart Globe Holdings Limited ( HKG:1481 ) shares have continued their recent momentum with a 26% gain in the last month...

Despite an already strong run, Jinhai Medical Technology Limited ( HKG:2225 ) shares have been powering on, with a gain...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses is...

Hua Hong Semiconductor Limited ( HKG:1347 ) shareholders would be excited to see that the share price has had a great...

Haidilao International Holding Ltd. recently completed a major leadership reshuffle, with long-time chairman Zhang Yong assuming the chief executive officer role and four younger executives promoted to the board, while several existing executive directors, including the former CEO, resigned. This overhaul signals an emphasis on grooming internally trained, operations-focused leaders drawn from regional management and product development roles, potentially influencing how the group executes...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Alibaba Health Information Technology Limited ( HKG:241 ) shareholders would be excited to see that the share price has...

Key Insights Planetree International Development's significant insider ownership suggests inherent interests in...

ASMPT Limited ( HKG:522 ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...

Zhong Jia Guo Xin Holdings Company Limited ( HKG:899 ) shareholders (or potential shareholders) will be happy to see...

As Asian markets continue to navigate a landscape marked by geopolitical tensions and economic shifts, investors are increasingly exploring diverse opportunities across the region. Penny stocks, often seen as smaller or newer companies with potential for growth, remain an intriguing segment for those seeking untapped value. In this article, we explore three Asian penny stocks that stand out for their financial strength and potential to offer compelling investment opportunities in today's...

LifeTech Scientific (SEHK:1302) is back in focus after two recent China NMPA decisions related to its vascular stent graft pipeline, raising fresh questions about how investors should think about the company’s product portfolio and valuation. See our latest analysis for LifeTech Scientific. Those two NMPA decisions have arrived during a period of renewed interest in the stock, with a 1 day share price return of 4.88%, a 7 day return of 9.55% and a 30 day return of 12.42%. However, the 90 day...

China Jinmao Holdings Group (SEHK:817) has released unaudited contracted sales figures for December and for the full year 2025, giving investors a fresh data point on project sales momentum and capital deployment. See our latest analysis for China Jinmao Holdings Group. The new contracted sales update lands after a mixed year for the stock, with a 1 month share price return of 6.56% and a 1 year total shareholder return of 50.53%. However, the 3 year and 5 year total shareholder returns...

Luye Pharma Group (SEHK:2186) is in focus after Chinese regulators accepted a New Drug Application for a new Ruoxinlin indication targeting Generalized Anxiety Disorder, supported by Phase III data in a large patient population. See our latest analysis for Luye Pharma Group. The NDA news has arrived after a mixed period for Luye Pharma Group. The 30 day share price return is 5.99%, while the 90 day share price return shows a 16.16% decline. The 1 year total shareholder return of 49.75%...